Biotech Bumble: ETFs Fall to 2014 Lows

More bad price action out of the biotechnology sector Thursday and that underscores the precarious technical conditions being faced some exchange traded funds that were beloved just several weeks ago. Here is a brief recap of just how bad biotech stocks and ETFs have been since the end of February:...